Ultragenyx Pharmaceutical Inc. earnings per share and revenue

RARE earnings per share for the last quarter are -1.52 USD whereas the estimation was -1.66 USD which accounts for 8.47% surprise. Company revenue for the same period amounts to 147.03 M USD despite the estimated figure of 123.20 M USD. Estimated earnings per share for the next quarter are -1.48 USD, and revenue is expected to reach 135.28 M USD. Also watch annual changes over time to get a bigger picture of RARE earnings per share and revenue dynamics.